198 related articles for article (PubMed ID: 31168940)
1. Mechanism of Oleogel-S10: A triterpene preparation for the treatment of epidermolysis bullosa.
Schwieger-Briel A; Ott H; Kiritsi D; Laszczyk-Lauer M; Bodemer C
Dermatol Ther; 2019 Jul; 32(4):e12983. PubMed ID: 31168940
[TBL] [Abstract][Full Text] [Related]
2. Oleogel-S10 in Dystrophic Epidermolysis Bullosa: A Case Series Evaluating the Impact on Wound Burden Over Two Years.
Torres Pradilla M; Álvarez E; Novoa M; Lozano I; Trujillo M
Adv Ther; 2024 Feb; 41(2):867-877. PubMed ID: 38170434
[TBL] [Abstract][Full Text] [Related]
3. Oleogel-S10 Phase 3 study "EASE" for epidermolysis bullosa: study design and rationale.
Kern JS; Schwieger-Briel A; Löwe S; Sumeray M; Davis C; Martinez AE
Trials; 2019 Jun; 20(1):350. PubMed ID: 31186047
[TBL] [Abstract][Full Text] [Related]
4. Betulin-Based Oleogel to Improve Wound Healing in Dystrophic Epidermolysis Bullosa: A Prospective Controlled Proof-of-Concept Study.
Schwieger-Briel A; Kiritsi D; Schempp C; Has C; Schumann H
Dermatol Res Pract; 2017; 2017():5068969. PubMed ID: 28611842
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of Oleogel-S10 (birch triterpenes) for epidermolysis bullosa: results from the phase III randomized double-blind phase of the EASE study.
Kern JS; Sprecher E; Fernandez MF; Schauer F; Bodemer C; Cunningham T; Löwe S; Davis C; Sumeray M; Bruckner AL; Murrell DF;
Br J Dermatol; 2023 Jan; 188(1):12-21. PubMed ID: 36689495
[TBL] [Abstract][Full Text] [Related]
6. Birch Bark Extract: A Review in Epidermolysis Bullosa.
Heo YA
Drugs; 2023 Sep; 83(14):1309-1314. PubMed ID: 37658982
[TBL] [Abstract][Full Text] [Related]
7. Lack of activity of betulin-based Oleogel-S10 in the treatment of actinic keratoses: a randomized, multicentre, placebo-controlled double-blind phase II trial.
Pflugfelder A; Andonov E; Weide B; Dirschka T; Schempp C; Stockfleth E; Stratigos A; Krüger-Krasagakis S; Bauer J; Garbe C; Eigentler TK
Br J Dermatol; 2015 Apr; 172(4):926-32. PubMed ID: 25124939
[TBL] [Abstract][Full Text] [Related]
8. OLEOGEL-S10 TO ACCELERATE HEALING OF DONOR SITES: MONOCENTRIC RESULTS OF PHASE III CLINICAL TRIAL.
Lipový B; Fiamoli M; Mager R; Jelínková Z; Jarkovský J; Chaloupková Z; Holoubek J; Suchánek I; Brychta P
Acta Chir Plast; 2018; 59(3-4):129-134. PubMed ID: 29651853
[TBL] [Abstract][Full Text] [Related]
9. Betulin wound gel accelerated healing of superficial partial thickness burns: Results of a randomized, intra-individually controlled, phase III trial with 12-months follow-up.
Frew Q; Rennekampff HO; Dziewulski P; Moiemen N; ; Zahn T; Hartmann B
Burns; 2019 Jun; 45(4):876-890. PubMed ID: 30559054
[TBL] [Abstract][Full Text] [Related]
10. The Wound Healing Properties of Betulin from Birch Bark from Bench to Bedside.
Scheffler A
Planta Med; 2019 May; 85(7):524-527. PubMed ID: 30856673
[TBL] [Abstract][Full Text] [Related]
11. Clinical trial of Oleogel-S10 (birch bark extract gel) in epidermolysis bullosa.
Br J Dermatol; 2023 Jan; 188(1):e4. PubMed ID: 36689535
[No Abstract] [Full Text] [Related]
12. From a traditional medicinal plant to a rational drug: understanding the clinically proven wound healing efficacy of birch bark extract.
Ebeling S; Naumann K; Pollok S; Wardecki T; Vidal-Y-Sy S; Nascimento JM; Boerries M; Schmidt G; Brandner JM; Merfort I
PLoS One; 2014; 9(1):e86147. PubMed ID: 24465925
[TBL] [Abstract][Full Text] [Related]
13. Accelerated reepithelialization by triterpenes: proof of concept in the healing of surgical skin lesions.
Metelmann HR; Brandner JM; Schumann H; Bross F; Fimmers R; Böttger K; Scheffler A; Podmelle F
Skin Pharmacol Physiol; 2015; 28(1):1-11. PubMed ID: 25034442
[TBL] [Abstract][Full Text] [Related]
14. Physical, chemical and pharmacological characterization of a new oleogel-forming triterpene extract from the outer bark of birch (betulae cortex).
Laszczyk M; Jäger S; Simon-Haarhaus B; Scheffler A; Schempp CM
Planta Med; 2006 Dec; 72(15):1389-95. PubMed ID: 17091432
[TBL] [Abstract][Full Text] [Related]
15. Treatment of actinic keratoses with a novel betulin-based oleogel. A prospective, randomized, comparative pilot study.
Huyke C; Reuter J; Rödig M; Kersten A; Laszczyk M; Scheffler A; Nashan D; Schempp C
J Dtsch Dermatol Ges; 2009 Feb; 7(2):128-33. PubMed ID: 18808378
[TBL] [Abstract][Full Text] [Related]
16. EASE-y does it: Oleogel-S10 for epidermolysis bullosa wounds.
Mellerio JE
Br J Dermatol; 2023 Jan; 188(1):10-11. PubMed ID: 36689525
[No Abstract] [Full Text] [Related]
17. Dystrophic epidermolysis bullosa pruriginosa in a mother and daughter successfully treated by low dose cyclosporine.
Tarutani M; Shiga T; Nakajima K; Nakano H; Sawamura D; Sano S
Eur J Dermatol; 2013; 23(5):727-9. PubMed ID: 24126452
[No Abstract] [Full Text] [Related]
18. Oleogel Formulations for the Topical Delivery of Betulin and Lupeol in Skin Injuries-Preparation, Physicochemical Characterization, and Pharmaco-Toxicological Evaluation.
Pârvănescu Pană RD; Watz CG; Moacă EA; Vlaia L; Marcovici I; Macașoi IG; Borcan F; Olariu I; Coneac G; Drăghici GA; Crăiniceanu Z; Flondor Ionescu D; Enache A; Dehelean CA
Molecules; 2021 Jul; 26(14):. PubMed ID: 34299450
[TBL] [Abstract][Full Text] [Related]
19. Reliability of photographic analysis of wound epithelialization assessed in human skin graft donor sites and epidermolysis bullosa wounds.
Rennekampff HO; Fimmers R; Metelmann HR; Schumann H; Tenenhaus M
Trials; 2015 May; 16():235. PubMed ID: 26018577
[TBL] [Abstract][Full Text] [Related]
20. Epidermolysis bullosa in animals: a review.
Medeiros GX; Riet-Correa F
Vet Dermatol; 2015 Feb; 26(1):3-13, e1-2. PubMed ID: 25354580
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
